Screener
Nuvation Bio NUVB Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The source filing: Nuvation Bio’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:55 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336646
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Total liabilities | 490,639 | 289,106 |
| Commitments and contingencies (Note 10) | ||
| Stockholders’ equity | ||
| Class A and Class B common stock and additional paid in capital, $0.0001 par value per share; 1,060,000,000 (Class A 1,000,000,000, Class B 60,000,000) shares authorized as of June 30, 2026 and December 31, 2025 respectively, 349,822,479 (Class A 348,822,479, Class B 1,000,000) and 346,503,675 (Class A 345,503,675, Class B 1,000,000) shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 1,429,288 | 1,421,273 |
| Accumulated deficit | (1,172,813) | (1,115,370) |
| Accumulated other comprehensive loss | (2,611) | (187) |
| Total stockholders’ equity | 253,864 | 305,716 |
| Total liabilities and stockholders’ equity | $744,503 | $594,822 |
Item 1. Financial Statements.
FAQ
- What is Nuvation Bio's common stock?
- Nuvation Bio (NUVB) reported common stock of $1.43B in Q2 2026.
- How has Nuvation Bio's common stock changed year-over-year?
- Nuvation Bio's common stock increased by 2.4% year-over-year, from $1.4B to $1.43B.
- What is the long-term trend for Nuvation Bio's common stock?
- Over 5 years (2020 to 2025), Nuvation Bio's common stock has grown at a 3.9% compound annual growth rate (CAGR), from $1.17B to $1.42B.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Nuvation Bio's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude